Today I am posting Part 2 of my interview with Drs. Lander and Berman of the Cell Surgical Network. You can read Part 1 here, which is an interesting look inside the Network. The final portion of this blog post series, Part 3, is my take on their answers and you might not be surprised that […]
Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use Read More »
The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1,
Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »
On November 18 in Washington, D.C. the Institute of Medicine (IOM) of the National Academy of Sciences will hold a workshop on stem cell therapies. The meeting (agenda here) is also co-sponsored by ISSCR. I have some major concerns about this meeting. In principle and in a general sense, I believe this is the kind of meeting and
Puzzling Institute of Medicine stem cell workshop Read More »
Nominations for Stem Cell Person of the Year 2013 closed last night and I ended up with a remarkable list of 30 nominees. I have included a few sentences about each one below, often taking verbiage directly from the nominator. The online voting on these nominees will start soon. The top vote getters will move
This is a guest post by Dr. Chris Centeno as I aim to bring in different viewpoints. By Christopher J. Centeno, M.D. We have noted an explosion in the number of stem cell clinics over the past several years. There’s not a day that goes by that I don’t see several new ones pop up on
Dr. Chris Centeno Guest Post on Risky Surge of Newbie Stem Cell Clinics Read More »
I’ve been fortunate to interview some of the greats in the stem cell field for this blog and host debates between key players. Please note that just because I have interviewed folks does not mean I agree with them or that they agree with me. The point is to establish dialogue on key issues. As
Interviews with leaders and top players in the stem cell field Read More »
I recently had a phone interview with Dr. Arnold Caplan, the founder of the MSC field. You can read parts 1 and 2 of the interview here and here. Today’s post, part 3, is focused on clinical use of MSCs. I want to start off today’s post with a wonderful quote from Caplan: “All MSCs
Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior
Nuggets and pyrite in Businessweek article on Celltex Read More »
What does the future hold for the privately-held Texas stem cell clinic, Celltex, that had given Governor Perry a stem cell transplant? I put up a poll a few days ago asking this question and the results have been striking. By way of background, it’s been a complicated few weeks for Celltex. Almost a month ago, I
Poll indicates major pessimism on future of Texas stem cell clinic, Celltex Read More »
As I first reported, the FDA conducted a two-week audit of Texas adult stem cell firm, Celltex, sometime in April. Today I received a copy of the so-called “483 report” of that audit. It is basically a summary of problematic issues that the FDA says need to addressed. The FDA report is cause for some
Surprising FDA audit report of Celltex a blow to dubious stem cell clinics Read More »